Patrick John Flynn - Net Worth and Insider Trading
Patrick John Flynn Net Worth
The estimated net worth of Patrick John Flynn is at least $6,881 dollars as of 2024-09-20. Patrick John Flynn is the Director of NRX Pharmaceuticals Inc and owns about 4,196 shares of NRX Pharmaceuticals Inc (NRXP) stock worth over $6,881. Details can be seen in Patrick John Flynn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick John Flynn has not made any transactions after 2022-11-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patrick John Flynn
Patrick John Flynn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick John Flynn owns 1 companies in total, including NRX Pharmaceuticals Inc (NRXP) .
Click here to see the complete history of Patrick John Flynn’s form 4 insider trades.
Insider Ownership Summary of Patrick John Flynn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NRXP | NRX Pharmaceuticals Inc | 2022-11-28 | director |
Patrick John Flynn Latest Holdings Summary
Patrick John Flynn currently owns a total of 1 stock. Patrick John Flynn owns 4,196 shares of NRX Pharmaceuticals Inc (NRXP) as of November 28, 2022, with a value of $6,881.
Latest Holdings of Patrick John Flynn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals Inc | 2022-11-28 | 4,196 | 1.64 | 6,881 |
Holding Weightings of Patrick John Flynn
Patrick John Flynn Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick John Flynn has made a total of 1 transactions in NRX Pharmaceuticals Inc (NRXP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NRX Pharmaceuticals Inc is the acquisition of 1,175 shares on November 28, 2022, which cost Patrick John Flynn around $14,688.
Insider Trading History of Patrick John Flynn
- 1
Patrick John Flynn Trading Performance
GuruFocus tracks the stock performance after each of Patrick John Flynn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick John Flynn is -18.4%. GuruFocus also compares Patrick John Flynn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick John Flynn within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patrick John Flynn's insider trading performs compared to the benchmark.
Performance of Patrick John Flynn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12 | | | | | |
| Relative Return to S&P 500(%) | -7.44 | | | | | |
Patrick John Flynn Ownership Network
Patrick John Flynn Owned Company Details
What does NRX Pharmaceuticals Inc do?
Who are the key executives at NRX Pharmaceuticals Inc?
Patrick John Flynn is the director of NRX Pharmaceuticals Inc. Other key executives at NRX Pharmaceuticals Inc include Interim CFO Richard Clavano Narido , director & 10 percent owner & Chief Scientist Jonathan C Javitt , and director & Chief Executive Officer Stephen H Willard .
NRX Pharmaceuticals Inc (NRXP) Insider Trades Summary
Over the past 18 months, Patrick John Flynn made no insider transaction in NRX Pharmaceuticals Inc (NRXP). Other recent insider transactions involving NRX Pharmaceuticals Inc (NRXP) include a net purchase of 300,000 shares made by Jonathan C Javitt , a net purchase of 70,000 shares made by Chaim Hurvitz , and a net purchase of 35,000 shares made by Aaron Gorovitz .
In summary, during the past 3 months, insiders sold 0 shares of NRX Pharmaceuticals Inc (NRXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NRX Pharmaceuticals Inc (NRXP) were sold and 40,500 shares were bought by its insiders, resulting in a net purchase of 40,500 shares.
NRX Pharmaceuticals Inc (NRXP)'s detailed insider trading history can be found in Insider Trading Tracker table.
NRX Pharmaceuticals Inc Insider Transactions
Patrick John Flynn Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick John Flynn. You might contact Patrick John Flynn via mailing address: 1201 North Market Street, Suite 111, Wilmington De 19801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
